Drugs / bipuvacaine
last change Jul 2021 re-read 2 minutes ago

bipuvacaine

Developed for
chronic pain syndrome

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03985280 Comparator Jun 2018 → Jun 2020 chronic pain syndrome Jorge Orduña-Valls Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as bipuvacaine “we will administer 10 mg of bipuvacaine, and 40 mg triamcinolone hexacetonide.” NCT03985280